GlassScriptPhysician profile
Robert C Weinschenk
NPI 1639589732
$2,836.87
in general payments reported to CMS, 2019-2025
11 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $234 · 2021: $707 · 2022: $503 · 2023: $396 · 2024: $178 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,758.55 | 2019-2025 | Mako, Infinity, Gamma |
| Onkos Surgical, INC. | $369.65 | 2019-2024 | Eleos Limb Salvage System |
| Trice Medical, INC. | $150.85 | 2023 | |
| Sanara Medtech INC. | $146.40 | 2022 | |
| Illuminoss Medical, INC. | $140.19 | 2022-2023 | Photodynamic Bone Stabilization Procedure Pack |
| Depuy Synthes Sales INC. | $112.50 | 2021 | |
| Ferring Pharmaceuticals INC. | $53.93 | 2022-2024 | Euflexxa |
| Osteocentric Technologies, INC. | $44.88 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Kerecis Limited | $24.67 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Siemens Medical Solutions USA, INC. | $19.13 | 2023 | Multitom Rax |
| Sanofi-Aventis U.S. LLC | $16.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Weinschenk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.